- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager
Checklist คุณสมบัติตามเกณฑ์ share swap
(3) -103% Elimination (73) (41) 6 108% 115% (228) (134) 41% Profit attributable to owners of the Company 918 1,316 1,386 51% 5% 4,773 5,778 21% Basic earnings per share (Baht) 0.67 0.96 1.01 3.47 4.20
Development Plc. would like to inform its financial results for the year 2019 which ended on 31 December 2019. The Company and its subsidiaries reported a net profit of THB 177.45 million or earnings per share
Networks Limited (BMN) On March 27, 2019, the Company purchased 5.08 Million ordinary shares of BMN, which is the subsidiary company, equal to 20 percent of its issued and paid-up share capital from its
”), with 51.0% and 49.0% of registered and paid-up capital of CVHLUX as of 30 September 2017, respectively. CVHLUX is a holding company which invests in 100% share of the registered and paid-up capital of
Company will purchase IGE’s existing ordinary share from ES after the approval of the Extraordinary General Meeting of Shareholders No.1/2018 to be held on June15, 2018 to issue and offer new ordinary
) -205% -183% 5,608 2,463 -56% Basic earnings per share (Baht) 1.07 1.35 (1.12) 4.07 1.79 Note: 1/ EBITDA from Refinery Business of the Company, BCP Trading Pte. Ltd. and share of profit associated
approval of the acquisition from the Comapany’s Board of Director No. 5/2017 held on 31 October 2017. The Share Purchase Agreement will be effective after Board of Director’s approval. 2) Related Contract